Transmission of tuberculosis in a south African community with a high prevalence of HIV infection

Journal of Infectious Diseases

Volumn 211, Issue 1, 2015, Pages 53-61

  Middelkoop, Keren ^a,b   Mathema, Barun ^f,g   Myer, Landon ^c   Shashkina, Elena ^g   Whitelaw, Andrew ^d,e   Kaplan, Gilla ^g   Kreiswirth, Barry ^g   Wood, Robin ^a,b   Bekker, Linda Gail ^a,b  

^a Institute of Infectious Disease and Molecular Medicine   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f Department of Medicine   (United States)

^g PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

genotyping.; HIV; molecular epidemiology; transmission; tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY; DEMOGRAPHY; DISEASE TRANSMISSION; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTH AFRICA; TUBERCULOSIS; GENETICS; HIV INFECTIONS; MICROBIOLOGY; TRANSMISSION; VIROLOGY;

ANTIRETROVIRUS AGENT;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SOUTH AFRICA; TUBERCULOSIS;

EID: 84922454993     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu403     Document Type: Article

References (38)

1. World Health Organization. Global tuberculosis report, 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656-eng.pdf. Accessed 11 March 2014.
2. Fine PE, Small PM. Exogenous reinfection in tuberculosis. N Engl J Med 1999; 341:1226-7.
3. Bauer J, Yang Z, Poulsen S, Andersen AB. Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection. J Clin Microbiol 1998; 36:305-8.
4. Verver S, Warren RM, Munch Z, et al. Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol 2004; 33:351-7.
5. Glynn JR, Crampin AC, Yates MD, et al. The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi. J Infect Dis 2005; 192:480-7.
6. Lockman S, Sheppard JD, Braden CR, et al. Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population- based prospective study of 301 pulmonary tuberculosis patients. J Clin Microbiol 2001; 39:1042-7.
7. Wilkinson D, Pillay M, Crump J, Lombard C, Davies GR, Sturm AW. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997; 2:747-53.
8. Asiimwe BB, Joloba ML, Ghebremichael S, et al. DNA restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from HIV-seropositive and HIV-seronegative patients in Kampala, Uganda. BMC Infect Dis 2009; 9:12.
9. Middelkoop K, Bekker LG, Mathema B, et al. Factors affecting tuberculosis strain success over 10 years in a high TB and HIV burdened community. Int J Epidemiol 2014; 43:1114-22.
10. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 2007; 175:87-93.
11. Middelkoop K, Bekker LG, Myer L, et al. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 2011; 56:263-9.
12. Andrews JR, Wood R, Bekker L-G, Middelkoop K, Walensky RP. Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. J Infect Dis 2012; 206:543-51.
13. Middelkoop K, Bekker LG, Myer L, et al. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med 2010; 182:1080-5.
14. Kranzer K, van Schaik N, Karmue U, et al. High prevalence of selfreported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. PLoS One 2011; 6:e25244.
15. South African Department of Health. National antiretroviral treatment guidelines, 2004. http://www.hst.org.za/uploads/files/sa-ART-Guidelines1. pdf. Accessed 11 March 2014.
16. Sanne I, Orrell C, Fox MP, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet 2010; 376:33-40.
17. Department of Health RSA. National tuberculosis management guidelines, 2009. http://familymedicine.ukzn.ac.za/Libraries/Guidelines-Protocols/TB-Guidelines-2009.sflb.ashx. Accessed 11 March 2014.
18. Cape Town TB Control. Progress report 1997-2003. Cape Town, South Africa: Health Systems Trust, 2004.
19. Middelkoop K, Bekker LG, Myer L, Dawson R, Wood R. Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults. Clin Infect Dis 2008; 47:349-55.
20. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006; 19:658-85.
21. Murray M, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol 2002; 155:565-71.
22. Fenner L, Egger M, Bodmer T, et al. HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genet 2013; 9:e1003318.
23. Middelkoop K, Bekker LG, Mathema B, et al. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J Infect Dis 2009; 200:1207-11.
24. Cowley D, Govender D, February B, et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis 2008; 47:1252-9.
25. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326:231-5.
26. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545-50.
27. Dooley SW, Villarino ME, Lawrence M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992; 267:2632-4.
28. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20:1605-12.
29. Middelkoop K, Bekker LG, Liang H, et al. Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study. BMC Infect Dis 2011; 11:156.
30. Bloch AB, Snider DE Jr. How much tuberculosis in children must we accept? Am J Public Health 1986; 76:14-5.
31. Johnstone-Robertson SP, Mark D, Morrow C, et al. Social mixing patterns within a South African township community: implications for respiratory disease transmission and control. Am J Epidemiol 2011; 174:1246-55.
32. Ayles H, Muyoyeta M, Du TE, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet 2013; 382:1183-94.
33. Braden CR, Templeton GL, Cave MD, et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997; 175:1446-52.
34. van der Spuy GD, van Helden PD, Warren RM. Effect of study duration on the interpretation of tuberculosis molecular epidemiology investigations. Tuberc Edinb 2009; 89:238-42.
35. Vynnycky E, NagelkerkeN, BorgdorffMW, van SoolingenD, van Embden JDFine PE. The effect of age and study duration on the relationship between clustering of DNA fingerprint patterns and the proportion of tuberculosis disease attributable to recent transmission. Epidemiol Infect 2001; 126:43-62.
36. Murray M. Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis 2002; 8:363-9.
37. Glynn JR, Vynnycky E, Fine PE. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999; 149:366-71.
38. van der Spuy GD, Kremer K, Ndabambi SL, et al. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberc Edinb 2009; 89:120-5.